CD8A and neoplasm: Although this finding was originally made with tumor-infiltrating CD8+ T cells, PD-1+ CD8+ T cells from peripheral blood, which can be more readily obtained than their counterpart within tumor, also likely represents a subpopulation rich in antitumor activity, from which more active ACT products could be generated than starting with a non-selected CD8+ T cell pool.